Researchers have developed a deep learning model that can spot longitudinal changes in patients' brain imaging that could be indicative of cancer recurrence.
Michael Reardon, MD, detailed five-year data out of ACC.25 that found Medtronic's Evolut TAVR platform performs as well as SAVR—and even better in some ways.
Reviewing data from more than 6,000 patients, researchers found little evidence of the "obesity paradox" observed elsewhere. Underweight TAVR patients, however, may face some significant long-term risks.
The Millipede 088 was designed to treat large vessel occlusion stroke patients by “ingesting” the blood clot as opposed to dragging it through the patient’s blood vessels.
India-based Meril Life Sciences has been manufacturing its Myval transcatheter heart valves for years, but the technology has not yet gained FDA approval. This latest head-to-head comparison included data from more than 1,000 TAVR patients.
Compared to freehand techniques during procedures requiring needle positioning, robot assistance results in fewer adjustments, even for seasoned interventional radiologists.
When it comes to assessing patients with suspected pulmonary embolism, contrast-enhanced CT pulmonary angiography has no diagnostic edge over a certain free-breathing, unenhanced MRI perfusion protocol.
New research suggests that the tissue environment where microcalcifications of the breast are formed could hold clues into how breast cancer progresses.
Given the less invasive nature of focused ultrasound procedures, researchers suggest that it could open the door for disease management options catered to a wider variety of patients.
Some SGLT2 inhibitors have been linked to significant improvements in HF outcomes, but what about sotagliflozin? We spoke with Bertram Pitt, MD, to learn more.
Many radiation oncologists are not formerly trained in imaging interpretation, and radiologists’ collaborative participation in care planning can help to catch errors, experts wrote recently.
